Jim Simons Harvard Bioscience Inc Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 724,078 shares of HBIO stock, worth $1.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

724,078

Previous 745,278 2.84%

Holding current value

$1.65 Million

Previous $2.12 Million 8.33%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$2.64 - $3.54 $55,968 - $75,048	-21,200 Reduced 2.84%	724,078 $1.95 Million
Q2 2024 Aug 09, 2024	BUY	$2.77 - $4.63 $118,556 - $198,164	42,800 Added 6.09%	745,278 $2.12 Million
Q1 2024 May 13, 2024	SELL	$4.02 - $5.39 $71,957 - $96,481	-17,900 Reduced 2.48%	702,478 $2.98 Million
Q4 2023 Feb 13, 2024	SELL	$4.0 - $5.49 $97,200 - $133,407	-24,300 Reduced 3.26%	720,378 $3.85 Million
Q3 2023 Nov 14, 2023	SELL	$4.0 - $5.82 $30,116 - $43,818	-7,529 Reduced 1.0%	744,678 $3.2 Million
Q2 2023 Aug 11, 2023	BUY	$4.19 - $6.16 $93,018 - $136,752	22,200 Added 3.04%	752,207 $4.13 Million
Q1 2023 May 12, 2023	SELL	$2.45 - $4.22 $10,535 - $18,146	-4,300 Reduced 0.59%	730,007 $3.07 Million
Q4 2022 Feb 13, 2023	SELL	$2.12 - $2.86 $248,377 - $335,074	-117,159 Reduced 13.76%	734,307 $2.03 Million
Q3 2022 Nov 14, 2022	SELL	$2.33 - $3.92 $349,024 - $587,200	-149,796 Reduced 14.96%	851,466 $2.18 Million
Q2 2022 Aug 12, 2022	BUY	$3.28 - $6.42 $173,239 - $339,085	52,817 Added 5.57%	1,001,262 $3.61 Million
Q1 2022 May 13, 2022	BUY	$5.16 - $7.14 $219,300 - $303,450	42,500 Added 4.69%	948,445 $5.89 Million
Q4 2021 Feb 11, 2022	SELL	$6.37 - $8.18 $1.09 Million - $1.39 Million	-170,500 Reduced 15.84%	905,945 $6.39 Million
Q3 2021 Nov 12, 2021	SELL	$6.98 - $8.47 $1.1 Million - $1.33 Million	-156,900 Reduced 12.72%	1,076,445 $7.51 Million
Q2 2021 Aug 13, 2021	SELL	$5.44 - $8.4 $1.06 Million - $1.63 Million	-194,300 Reduced 13.61%	1,233,345 $10.3 Million
Q1 2021 May 13, 2021	BUY	$3.91 - $6.99 $825,792 - $1.48 Million	211,200 Added 17.36%	1,427,645 $7.8 Million
Q4 2020 Feb 10, 2021	SELL	$3.0 - $4.5 $104,709 - $157,063	-34,903 Reduced 2.79%	1,216,445 $5.22 Million
Q3 2020 Nov 13, 2020	BUY	$2.75 - $4.2 $602,849 - $920,715	219,218 Added 21.24%	1,251,348 $3.77 Million
Q2 2020 Aug 13, 2020	BUY	$2.12 - $3.14 $753,236 - $1.12 Million	355,300 Added 52.49%	1,032,130 $3.2 Million
Q1 2020 May 14, 2020	BUY	$1.42 - $3.29 $199,978 - $463,330	140,830 Added 26.27%	676,830 $1.5 Million
Q4 2019 Feb 13, 2020	BUY	$2.45 - $3.25 $50,930 - $67,561	20,788 Added 4.03%	536,000 $1.64 Million
Q3 2019 Nov 13, 2019	SELL	$1.59 - $3.47 $613,402 - $1.34 Million	-385,788 Reduced 42.82%	515,212 $1.58 Million
Q2 2019 Aug 12, 2019	BUY	$1.93 - $4.59 $539,435 - $1.28 Million	279,500 Added 44.97%	901,000 $1.8 Million
Q1 2019 May 14, 2019	SELL	$2.77 - $4.38 $217,195 - $343,435	-78,410 Reduced 11.2%	621,500 $2.68 Million
Q4 2018 Feb 13, 2019	BUY	$3.03 - $5.0 $2.12 Million - $3.5 Million	699,910 New	699,910 $2.23 Million

Others Institutions Holding HBIO

# of Institutions

107

Shares Held

32M

Call Options Held

1.2K

Put Options Held

1.2K

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $94.9M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account